Humanising Healthcare podcast Series 3 - 'Drug use and working with the LGBTQ+ community '

Listen to the podcast on Spotify: Drug use and working with the LGBTQ+ community

In this edition:

This week, Manasi is joined by Dr David Wood, Consultant, Physician and Clinician Toxicologist at Guys and St Thomas’ Hospital and Honorary Reader at King’s College London on the episode ‘Drug use and working with the LGBTQ+ community.’  They discuss the use of recreational drugs and new psychoactive substances in the LGBTQ+ community and the work David and peer have done to support better procedures to recognise and manage drug overdoses in bars and venues across London and more widely. 

Dr David Wood

Consultant Physician and Clinical Toxicologist and Honorary Reader in Clinical Toxicology

Dr David Wood is a Consultant Physician and Clinical Toxicologist at the Trust and Reader in Clinical Toxicology at King’s College London. He has a clinical, research and academic interest in the epidemiology of use of and acute harms related to recreational drugs, new psychoactive substances (NPS) and misused prescription medicines, the management of paracetamol overdose and cardiovascular drug toxicity. He is a member of the UK Advisory Council on the Misuse of Drugs (ACMD) and expert advisor to the European Union Drugs Agency (EUDA, formerly known as the European Monitoring Centre for Drugs and Drug Addiction), World Health Organisation and United Nations Office on Drugs and Crime (UNODC) in the area of recreational drugs and NPS.  

Manasi Nandi

Reader in Integrative Pharmacology

Manasi is a scientist and educator based within the Faculty of Life Sciences and Medicine. Her interdisciplinary research focuses on the extraction of new information from vital signs data, aiding research and clinical decision making, and identifying earlier alerts of disease. She has expertise in medicine discovery and development and the translation of laboratory findings into clinical practice. She is a fellow of the British Pharmacological Society, most recently supporting efforts to embed inclusive principles into the national curriculum. Inclusivity and accessibility are at the core of her teaching and research practice. She is the Development, Diversity and Inclusion lead for the School and Cancer and Pharmaceutical Science, supporting EDI activities at Faculty and College level. She launched the Humanising Healthcare seminar series in 2023.